VuMee announced that the company has taken on three new celebrity content providers: comedians Dexter Tucker and Guy Torry, as well as former Tennessee Titans and Philadelphia Eagles NFL star Jevon Kearse. The celebrities will be connecting with fans via VuMee’s technology.
VuMee is a digital advertising platform that is focused on bringing brands and personalities to consumers through video content. VuMee targets specific consumer segments to bring users media from companies, brands, and celebrities on PC and mobile platforms.
Guy Torry, a standup comic who has toured with the national Kings of Comedy show, has also guest-starred on TV series Martin, The X-Files, and NYPD Blue, as well as films American History X, Life, and Pearl Harbor. Dexter Tucker, sibling of Chris Tucker, is also a standup comic who has produced reality TV and film, and is currently touring with the play “The Lawd Done Sent Me a Man”. Jevon Kearse was an All-American at Florida before being drafted by the Tennessee Titans where he was named NFL Defensive Rookie of the Year. He has also played in two Super Bowls: with the titans and the Philadelphia Eagles.
Michael Spiegel, VuMee.com CEO, said, “We are thrilled to welcome these talented celebrities to VuMee’s growing roster of high profile content providers. Our platform gives them an opportunity for tremendous exposure to the benefit of our viewers.”
For more information, visit www.vumee.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The QualityStocks Daily Blog http://blog.qualitystocks.net
The QualityStocks Video Charts http://videocharts.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment